WallStreetZenWallStreetZen

NASDAQ: ADIL
Adial Pharmaceuticals Inc Stock

$1.31+0.01 (+0.77%)
Updated Jun 14, 2024
ADIL Price
$1.31
Fair Value Price
$1.98
Market Cap
$5.55M
52 Week Low
$0.77
52 Week High
$14.00
P/E
-0.42x
P/B
0.91x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$8.69M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.09
Operating Cash Flow
-$6M
Beta
0.64
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ADIL Overview

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ADIL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ADIL ($1.31) is undervalued by 33.98% relative to our estimate of its Fair Value price of $1.98 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ADIL ($1.31) is significantly undervalued by 33.98% relative to our estimate of its Fair Value price of $1.98 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ADIL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ADIL due diligence checks available for Premium users.

Be the first to know about important ADIL news, forecast changes, insider trades & much more!

ADIL News

Valuation

ADIL fair value

Fair Value of ADIL stock based on Discounted Cash Flow (DCF)
Price
$1.31
Fair Value
$1.98
Undervalued by
33.98%
ADIL ($1.31) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ADIL ($1.31) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ADIL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ADIL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.42x
Industry
-10.23x
Market
30.51x

ADIL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.91x
Industry
6.25x
ADIL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ADIL's financial health

Profit margin

Revenue
$0.0
Net Income
-$6.5M
Profit Margin
0%
ADIL's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$6.7M
Liabilities
$562.7k
Debt to equity
0.09
ADIL's short-term assets ($5.34M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ADIL's short-term assets ($5.34M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ADIL's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ADIL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.6M
Investing
$0.0
Financing
$3.8M
ADIL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ADIL vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ADIL$5.55M+0.92%-0.42x0.91x
LIXT$5.51M-2.78%-1.05x1.76x
KTTA$5.49M-7.70%-0.38x0.28x
CELZ$5.61M0.00%-1.11x0.61x
SNPX$5.69M+5.49%-0.16x0.26x

Adial Pharmaceuticals Stock FAQ

What is Adial Pharmaceuticals's quote symbol?

(NASDAQ: ADIL) Adial Pharmaceuticals trades on the NASDAQ under the ticker symbol ADIL. Adial Pharmaceuticals stock quotes can also be displayed as NASDAQ: ADIL.

If you're new to stock investing, here's how to buy Adial Pharmaceuticals stock.

What is the 52 week high and low for Adial Pharmaceuticals (NASDAQ: ADIL)?

(NASDAQ: ADIL) Adial Pharmaceuticals's 52-week high was $14.00, and its 52-week low was $0.77. It is currently -90.64% from its 52-week high and 71.24% from its 52-week low.

How much is Adial Pharmaceuticals stock worth today?

(NASDAQ: ADIL) Adial Pharmaceuticals currently has 4,233,308 outstanding shares. With Adial Pharmaceuticals stock trading at $1.31 per share, the total value of Adial Pharmaceuticals stock (market capitalization) is $5.55M.

Adial Pharmaceuticals stock was originally listed at a price of $101.25 in Jul 27, 2018. If you had invested in Adial Pharmaceuticals stock at $101.25, your return over the last 5 years would have been -98.71%, for an annualized return of -58.08% (not including any dividends or dividend reinvestments).

How much is Adial Pharmaceuticals's stock price per share?

(NASDAQ: ADIL) Adial Pharmaceuticals stock price per share is $1.31 today (as of Jun 14, 2024).

What is Adial Pharmaceuticals's Market Cap?

(NASDAQ: ADIL) Adial Pharmaceuticals's market cap is $5.55M, as of Jun 16, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Adial Pharmaceuticals's market cap is calculated by multiplying ADIL's current stock price of $1.31 by ADIL's total outstanding shares of 4,233,308.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.